{
    "title": "Hikma shares jump after improved sales outlook, COVID-19 drug deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8603297/Hikma-raises-drug-sales-outlook-profit-jumps-pandemic-demand.html",
    "date": "2020-08-07",
    "keywords": [
        "treatment",
        "aripaka",
        "profit",
        "companys",
        "deal",
        "coronavirus",
        "stock",
        "revenue",
        "division",
        "remdesivir",
        "covid19",
        "drug",
        "expectation",
        "olafsson",
        "outlook",
        "friday",
        "pence",
        "gmt",
        "top",
        "list",
        "index",
        "unit",
        "growth",
        "demand",
        "production",
        "hikmas",
        "facility",
        "frontrunner",
        "disease",
        "action",
        "support",
        "illness",
        "gilead",
        "importance",
        "source",
        "research",
        "note",
        "peel",
        "hunt",
        "buy",
        "rating",
        "hikma",
        "jordan",
        "business",
        "increase",
        "part",
        "boost",
        "partnership",
        "care",
        "performance",
        "driver",
        "march",
        "executive",
        "siggi",
        "firsthalf",
        "guidance",
        "range",
        "versus",
        "company",
        "dexamethasone",
        "uk",
        "study",
        "death",
        "group",
        "operating",
        "dividend",
        "share",
        "reporting",
        "pushkala",
        "bengaluru",
        "editing",
        "soni",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}